Last reviewed · How we verify
Indium-DTPA
Indium-DTPA is a Small molecule drug developed by Tim Corcoran. It is currently FDA-approved.
At a glance
| Generic name | Indium-DTPA |
|---|---|
| Sponsor | Tim Corcoran |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Multilevel Models of Therapeutic Response in the Lungs (PHASE1)
- Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT (PHASE2)
- 111 Indium CHX-A DTPA Trastuzumab (Indium-Herceptin) for Imaging Breast Cancer (EARLY_PHASE1)
- Repeatability and Response Study of Absorptive Clearance Scans (PHASE1)
- Imaging Airway Liquid Absorption in Cystic Fibrosis (NA)
- Absorptive Clearance in the Cystic Fibrosis Airway (NA)
- Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Indium-DTPA CI brief — competitive landscape report
- Indium-DTPA updates RSS · CI watch RSS
- Tim Corcoran portfolio CI
Frequently asked questions about Indium-DTPA
What is Indium-DTPA?
Indium-DTPA is a Small molecule drug developed by Tim Corcoran.
Who makes Indium-DTPA?
Indium-DTPA is developed and marketed by Tim Corcoran (see full Tim Corcoran pipeline at /company/tim-corcoran).
What development phase is Indium-DTPA in?
Indium-DTPA is FDA-approved (marketed).
Related
- Manufacturer: Tim Corcoran — full pipeline
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing